Cellbion CEO “We’ll Prove Orphan Drug Success...Next Month Is the Turning Point” 유진희 2025.11.17 오전 10:30 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 로딩중..